Table 1 Baseline general demographic and clinical characteristics of medium to high dose group
Low dose group (n = 620) | Medium to high dose group (n = 364) | High dose group (n = 34) | |
|---|---|---|---|
Age, years | |||
< 18, n (%) | 42 (6.8) | 32 (8.8) | 4 (11.8) |
≥ 18 and ≤ 40, n (%) | 402 (64.8) | 242 (66.5) | 27 (79.4) |
> 40, n (%) | 176 (28.4) | 90 (24.7) | 3 (8.8) |
Gender | |||
Male, n (%) | 245 (39.5) | 141 (38.7) | 11 (32.4) |
Female, n (%) | 375 (60.5) | 223 (61.3) | 23 (67.6%) |
Nationality | |||
Han, n (%) | 611 (98.5) | 361 (99.2) | 34 (100.0) |
Others, n (%) | 9 (1.5) | 3 (0.8) | 0 (0.0) |
Weight (kg) | |||
Mean ± SD | 65.97 ± 14.158 | 65.19 ± 14.037 | 69.17 ± 15.444 |
Anamnesis | |||
Yes, n (%) | 286 (46.1) | 46 (12.6) | 5 (14.7) |
No, n (%) | 334 (53.9) | 318 (87.4) | 29 (85.3) |
Medication history | |||
Yes, n (%) | 56 (9.0) | 193 (53.0) | 26 (76.5) |
No, n (%) | 564 (91.0) | 171 (47.0) | 8 (23.5) |